Zenas Biopharma
$18.15
17
-$0.22-1.2% Monday 21:00
Statistics
Day High
18.72
Day Low
17.6
52W High
44.6
52W Low
6.11
Volume
852,777
Avg. Volume
670,947
Mkt Cap
974.27M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Dividends
0%Dividend Yield
Jan 20
$0
Oct 19
$0.02
Jul 19
$0.02
Mar 19
$0.01
Jan 19
$0.01
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
25FebExpected
Expected EPS
-0.99855
Actual EPS
N/A
Financials
-1,372.95%Profit Margin
Unprofitable10MRevenue
-137.3MNet Income
Analyst Ratings
$41.80Average Price Target
The highest estimate is 55.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy 80%
Hold 20%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ZBIO. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody for various indications, including immunoglobulin G4-related disease, multiple sclerosis, systemic lupus erythematosus, and warm autoimmune hemolytic anemia. The company also develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; ZB001, an anti-insulin-like growth factor-1 receptor monoclonal antibody; and ZB005, an anti-active complement component 1s monoclonal antibody. Zenas BioPharma, Inc. was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc. in August 2023. The company was incorporated in 2019 and is based in Waltham, Massachusetts.
Show more...
CEO
Mr. Leon Oliver Moulder Jr., M.B.A.
Employees
130
Country
US
ISIN
US98937L1052
Listings
0 Comments
Share your thoughts
FAQ
What is Zenas Biopharma stock price today?▼
The current price of ZBIO is $18.15 USD — it has decreased by -1.2% in the past 24 hours. Watch Zenas Biopharma stock price performance more closely on the chart.
What is Zenas Biopharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Zenas Biopharma stocks are traded under the ticker ZBIO.
Is Zenas Biopharma stock price growing?▼
ZBIO stock has fallen by -9.57% compared to the previous week, the month change is a -47.39% fall, over the last year Zenas Biopharma has showed a +144.94% increase.
What is Zenas Biopharma market cap?▼
Today Zenas Biopharma has the market capitalization of 974.27M
When is the next Zenas Biopharma earnings date?▼
Zenas Biopharma is going to release the next earnings report on February 25, 2026.
What were Zenas Biopharma earnings last quarter?▼
ZBIO earnings for the last quarter are -1.22 USD per share, whereas the estimation was -1.04 USD resulting in a -17.57% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Zenas Biopharma revenue for the last year?▼
Zenas Biopharma revenue for the last year amounts to 10M USD.
What is Zenas Biopharma net income for the last year?▼
ZBIO net income for the last year is -137.3M USD.
Does Zenas Biopharma pay dividends?▼
Yes, ZBIO dividends are paid quarterly. The last dividend per share was 0 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Zenas Biopharma have?▼
As of February 03, 2026, the company has 130 employees.
In which sector is Zenas Biopharma located?▼
Zenas Biopharma operates in the Health Care sector.
When did Zenas Biopharma complete a stock split?▼
The last stock split for Zenas Biopharma was on May 24, 2018 with a ratio of 1:2.
Where is Zenas Biopharma headquartered?▼
Zenas Biopharma is headquartered in Waltham, US.